Benign Prostatic Hyperplasia
Conditions
Interventions
Sponsors
Shenzhen Luohu People's Hospital (The Third Affiliated Hospital of Shenzhen University)
Eligibility
Sex/Gender
Male
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate in the trial and sign a written informed consent form; 2. Aged between 50 and 80 years old (including 50 and 80 years old); 3. Meet the diagnosis of benign prostatic hyperplasia (BPH); 4. QoL score > 3, IPSS between 8 and 19 scores, maximum urinary flow rate < 15ml/s.
Exclusion criteria
Exclusion criteria: 1. Patient has been diagnosed with severe respiratory dysfunction or required oxygen therapy; 2. Patient with serious diseases of other systems such as severe cardiovascular disease, acute stroke, malignant tumor, severe mental illness, etc.; 3. Serum PSA>4 ng/mL; 4. The investigator judges any disease other than benign prostatic hyperplasia that can cause urinary symptoms or changes in urinary flow rate (eg, neurogenic bladder, bladder neck fibrosis, bladder tumor, urinary calculi, urethral stricture, phimosis or penis tumor, acute or chronic prostatitis, prostate cancer, acute and chronic urinary tract infection, acute and chronic renal failure, large (>5 cm) bladder diverticula, etc.); 5. Patient has participated in other clinical trial within 30 days; 6. Poor compliance or fail to complete the test according to the research plan; 7. Other situations that researchers think the patient is not suitable for the research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score (IPSS);Quality of Life (QoL) Score;Maximum Urinary Flow Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine; | — |
Countries
China
Contacts
Public ContactGuixiao Huang
Shenzhen Luohu People's Hospital (The Third Affiliated Hospital of Shenzhen University)
Outcome results
None listed